CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-17 | Horn Howard CFO | Sale | −2,393 | $31.93 | $76K | 200,384 |
| 2022-02-17 | Pang Phillip Chief Medical Officer | Sale | −3,009 | $31.93 | $96K | 89,768 |
| 2022-02-16 | Pang Phillip Chief Medical Officer | Option exercise | +5,000 | $1.53 | $8K | 97,777 |
| 2022-02-16 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $31.54 | $158K | 92,777 |
| 2022-02-16 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 52,591 | ||
| 2022-02-08 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 109,075 |
| 2022-02-08 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $33.94 | $47K | 107,700 |
| 2022-02-08 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 220,880 | ||
| 2022-02-02 | Pang Phillip Chief Medical Officer | Option exercise | +5,000 | $1.53 | $8K | 97,777 |
| 2022-02-02 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $34.52 | $173K | 92,777 |
| 2022-02-02 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 57,591 | ||
| 2022-01-25 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 109,075 |
| 2022-01-25 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $32.46 | $45K | 107,700 |
| 2022-01-25 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 222,255 | ||
| 2022-01-19 | Pang Phillip Chief Medical Officer | Option exercise | +5,000 | $1.53 | $8K | 97,777 |
| 2022-01-19 | Pang Phillip Chief Medical Officer | Sale | −2,458 | $34.59 | $85K | 95,319 |
| 2022-01-19 | Pang Phillip Chief Medical Officer | Sale | −2,542 | $35.52 | $90K | 92,777 |
| 2022-01-19 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 62,591 | ||
| 2022-01-18 | SATO VICKI L Director | Sale | −15,173 | $37.39 | $567K | 1,535,919 |
| 2022-01-11 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 109,075 |
Page 30 of 54 · 1,063 trades